Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings

Elnaem, Mohamed Hassan Abdelaziz and Nik Mohamed, Mohamad Haniki (2017) Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings. Value in Health, 20 (9). A486. ISSN 1098-3015

PDF - Published Version Restricted to Registered users only Download (56kB) | Request a copy

Abstract

Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment.

Item Type:	Article (Meeting Abstract)
Additional Information:	7472/58961
Uncontrolled Keywords:	lipid-lowering therapy, diabetes
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RM Therapeutics. Pharmacology > RM283 Endocrinotheraphy
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy > Department of Pharmacy Practice
Depositing User:	Dr Mohamed Elnaem
Date Deposited:	01 Nov 2017 15:43
Last Modified:	15 Jul 2022 10:34
URI:	http://irep.iium.edu.my/id/eprint/58961

Actions (login required)

View Item